Two vulnerabilities in the Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT allow an attacker within Bluetooth Low Energy (BLE) range to intercept sensitive health data in cleartext and perform a denial-of-service attack by monopolizing the device's connection slot. The vendor has not responded to coordination requests, meaning no official patch is currently available.
CVE-2026-52866
1 post
Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT (CVE-2026-50034, CVE-2026-52866)